1. Home
  2. GSIT vs ALLO Comparison

GSIT vs ALLO Comparison

Compare GSIT & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

HOLD

Current Price

$7.85

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$1.71

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIT
ALLO
Founded
1995
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
252.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
GSIT
ALLO
Price
$7.85
$1.71
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$8.60
AVG Volume (30 Days)
2.1M
2.9M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$24,024,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
22.00
N/A
52 Week Low
$1.62
$0.86
52 Week High
$18.15
$3.78

Technical Indicators

Market Signals
Indicator
GSIT
ALLO
Relative Strength Index (RSI) 60.26 70.82
Support Level $6.18 $1.30
Resistance Level $8.16 $1.54
Average True Range (ATR) 0.63 0.10
MACD 0.22 0.02
Stochastic Oscillator 71.24 75.21

Price Performance

Historical Comparison
GSIT
ALLO

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: